Physician

Jay P. Glover, M.D.

According to 2025 Medicare claims, Jay Glover, M.D. (NPI: 1184917957) practices ophthalmology in the Nashville-Davidson--Murfreesboro--Franklin, TN market, with the plurality of this provider's patient population coming from Dickson, TN. This provider's primary affiliated billing organization is TENNESSEE RETINA PC (NPI: 1497828321; TIN: 621042760) and primary practice location at 37055-2166.

Glover's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,108 traditional Medicare patients, billed 52,279 HCPCS/CPT codes, and received $3,186,185 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 839 prescription claims across 232 beneficiaries totaling $44,557 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 8 records totaling $497. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $25,486 to $3,186,185. Similarly, Part D prescription costs have risen steadily, from $5,882 to $44,557. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.2M2015 Medicare payment: $25,486 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $51,864 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $137,230 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $590,922 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $733,239 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,229,118 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,348,546 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,640,907 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,948,317 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,186,185 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015183284$25,486
2016392760$51,864
20173541,591$137,230
20185875,257$590,922
20197517,095$733,239
20209369,216$1,229,118
20219779,751$1,348,546
20229939,712$1,640,907
20231,06731,063$2,948,317
20241,10852,279$3,186,185

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$39K$77K2015 Drug cost: $5,882 (USD; Tot_Drug_Cst)2016 Drug cost: $4,447 (USD; Tot_Drug_Cst)2017 Drug cost: $14,644 (USD; Tot_Drug_Cst)2018 Drug cost: $26,993 (USD; Tot_Drug_Cst)2019 Drug cost: $38,467 (USD; Tot_Drug_Cst)2020 Drug cost: $54,481 (USD; Tot_Drug_Cst)2021 Drug cost: $72,655 (USD; Tot_Drug_Cst)2022 Drug cost: $77,258 (USD; Tot_Drug_Cst)2023 Drug cost: $74,078 (USD; Tot_Drug_Cst)2024 Drug cost: $44,557 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201569216$5,882
201671154$4,447
201797232$14,644
2018166547$26,993
2019179726$38,467
2020206825$54,481
2021219881$72,655
2022248960$77,258
2023249911$74,078
2024232839$44,557

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2751,988$657
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more149149$120
67028Injection of drug into eye4481,730$89
92014Established patient complete exam of visual system8831,428$81
92134Imaging of retina9902,511$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2336,350$7,743
CombiganBrimonidine Tartrate/Timolol281,175$6,036
Bromfenac SodiumBromfenac Sodium261,126$4,609
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol402,284$4,396
ProlensaBromfenac Sodium12502$4,172

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$497Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jay P. Glover, M.D.?

Tedicare shows public-source Medicare data for Jay P. Glover, M.D. (NPI 1184917957), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jay P. Glover, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jay P. Glover, M.D.?

Jay P. Glover, M.D. is linked to TENNESSEE RETINA PC (billing NPI 1497828321) in the available physician profile data.

Does Jay P. Glover, M.D. have Open Payments data?

Jay P. Glover, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.